353 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
, confirmation code: 5034750.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
Mission To discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our Values Innovation Passion
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
18 Mar 24
Strengthening Neuroscience Portfolio
8:56am
as legal counsel.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop
SC TO-T/A
EX-99
szw2 t6wg5
23 Feb 24
Third party tender offer statement (amended)
7:34am
8-K
EX-99.1
q17ljgow048z
14 Feb 24
Bristol Myers Squibb Recommends Stockholders Reject “Mini-Tender” Offer by Tutanota LLC
4:32pm
SC TO-T/A
EX-99
le1ok76pjncn7wbh5ig
12 Feb 24
Third party tender offer statement (amended)
7:34am
8-K
EX-99.1
qx7hhw
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
gfceyri
25 Jan 24
Third party tender offer statement
8:13am
SC TO-C
EX-99.1
2yey2hu1zdro6cgiwy
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.4
nw0q155ddcd9r49m
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.2
tzkic4
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.5
14r77l99
26 Dec 23
Information about tender offer
4:22pm
DFAN14A
EX-99.1
bdyermcf9 uowhlp0
22 Dec 23
Additional proxy materials by non-management
4:21pm
8-K
EX-99.1
thk97b
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
EX-99.2
y3dwh0k5tf3zqdjiig
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
on0eid13 3xhb4
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
w8j452l
10 Oct 23
Additional proxy materials by non-management
6:48am